{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2015"],"condition":["Rectal Neoplasms","Rectal Cancer","Cancer"],"disease":["Rectal Neoplasms","Rectal Cancer","Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2200370"],"location":["United Kingdom"],"study_start_month":["11"],"keyword":["CtDNA","Extramural Venous Invasion","Neoplasm DNA","MRI","EMVI","MrEMVI"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous Invasion","description":"This study does not involve randomization or treatment. Eligible patients have colorectal adenocarcinoma with no metastases eligible for curative surgery. A pre operative staging scan must have been completed within 6 weeks prior to surgery. Two x 20ml blood samples will be taken from each patient, one prior to and one during or within 24hrs after surgery. Patients are annually followed up to 3 years.","dates":{"creation":"2015-11-15"},"accession":"2200370","cross_references":{"ClinicalTrials___gov":["NCT02579278"]}}